Nasdaq

QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio

NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test receives Emergency Use Authorization by FDA The 4-plex test utilizes the high-throughput, automated testing capabilities of the NeuMoDx systems, which has ...
Business Wire

QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...
WLWT

Customers can get tested for flu, RSV, COVID-19 all at once at Kroger's Little Clinics

Customers can make sure they are getting the right treatment for their illnesses by taking a three-in-one multiplex test at Kroger's Little Clinics that test for the flu, RSV and COVID-19 all at ...
GEN

Multiplex PCR VHS Test for Genital Lesions

The PlexPCR ® VHS multiplex qPCR test offers a single-well solution to cover the detection and differentiation of the main causes of genital and oral lesions: herpes simplex virus types 1 and 2 (HSV-1 ...
Nasdaq

QIAGEN: NeuMoDx Multiplex Test Gets FDA Emergency Use Authorization To Differentiate COVID-19

(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...